ESSBIO-A Stock Overview
Primarily engages in the provision of sanitation services in Chile. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 2/6 |
| Dividends | 3/6 |
Essbio S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CL$15.00 |
| 52 Week High | CL$0 |
| 52 Week Low | CL$0 |
| Beta | -0.0028 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 33 Year Change | 0% |
| 5 Year Change | 0% |
| Change since IPO | -99.99% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| ESSBIO-A | CL Water Utilities | CL Market | |
|---|---|---|---|
| 7D | 0% | -1.2% | 0.4% |
| 1Y | 0% | 29.3% | 10.3% |
Return vs Industry: ESSBIO-A underperformed the CL Water Utilities industry which returned 33.1% over the past year.
Return vs Market: ESSBIO-A underperformed the CL Market which returned 10.7% over the past year.
Price Volatility
| ESSBIO-A volatility | |
|---|---|
| ESSBIO-A Average Weekly Movement | 0% |
| Water Utilities Industry Average Movement | 3.3% |
| Market Average Movement | 2.2% |
| 10% most volatile stocks in CL Market | 4.3% |
| 10% least volatile stocks in CL Market | 0.7% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine ESSBIO-A's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 1,287 | Cristian Vergara Castillo | www.essbio.cl |
Essbio S.A. primarily engages in the provision of sanitation services in Chile. It is involved in the construction and operation of public services for the production and distribution of drinking water; collection and disposal of wastewater; and treatment of liquid industrial waste. The company also provides laboratory services, chemical, biological, and other analysis.
Essbio S.A. Fundamentals Summary
| ESSBIO-A fundamental statistics | |
|---|---|
| Market cap | CL$388.43b |
| Earnings (TTM) | CL$26.61b |
| Revenue (TTM) | CL$240.05b |
14.6x
P/E Ratio1.6x
P/S RatioIs ESSBIO-A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ESSBIO-A income statement (TTM) | |
|---|---|
| Revenue | CL$240.05b |
| Cost of Revenue | CL$56.16b |
| Gross Profit | CL$183.88b |
| Other Expenses | CL$157.27b |
| Earnings | CL$26.61b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.01 |
| Gross Margin | 76.60% |
| Net Profit Margin | 11.09% |
| Debt/Equity Ratio | 158.8% |
How did ESSBIO-A perform over the long term?
See historical performance and comparison